UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045824
Receipt number R000052311
Scientific Title Effect of remimazolam and propofol anesthesia on autonomic nerve activities during Le Fort 1 osteotomy under general anesthesia.
Date of disclosure of the study information 2021/10/21
Last modified on 2024/03/31 11:31:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of remimazolam and propofol anesthesia on autonomic nerve activities during Le Fort 1 osteotomy under general anesthesia.

Acronym

Effect of remimazolam and propofol anesthesia on autonomic nerve activities.

Scientific Title

Effect of remimazolam and propofol anesthesia on autonomic nerve activities during Le Fort 1 osteotomy under general anesthesia.

Scientific Title:Acronym

Effect of remimazolam and propofol anesthesia on autonomic nerve activities.

Region

Japan


Condition

Condition

jaw deformity

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Using frequency analysis of heart rate variability and blood pressure variability to compare changes in autonomic nerve activity induced by surgical stimulation with remimazolam and propofol.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in heart rate variability and blood pressure variability before and after surgical stimulation with propofol and remimazolam.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Remimazolam started at 12 mg/kg/h by continuous intravenous infusion until the loss of consciousness, followed by 1 mg/kg/h to be adjusted as appropriate until the end of surgery.

Interventions/Control_2

Propofol started at 4.0mcg/ml continuous intravenous infusion until the loss of consciousness, followed by adjusted as appropriate until the end of surgery.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

45 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients aged 18-45 years scheduled for orthognathic surgery under general anesthesia and an American Society of Anesthesiologists physical status of 1.

Key exclusion criteria

ASA-PS II or higher, emergency surgery, inability to obtain consent from the patient, taking benzodiazepines, contraindications to the administration of drugs used in this study, and those under 18 years of age.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name kyotarou
Middle name
Last name koshika

Organization

Tokyo dental college

Division name

Department of Dental Anesthesiology

Zip code

101-0061

Address

2-9-18 Kanda Misaki, Chiyoda, Tokyo

TEL

03-6380-9113

Email

koshikakyotarou@tdc.ac.jp


Public contact

Name of contact person

1st name kyotarou
Middle name
Last name koshika

Organization

Tokyo dental college

Division name

Department of Dental Anesthesiology

Zip code

101-0061

Address

2-9-18 Kanda Misaki, Chiyoda, Tokyo

TEL

03-6380-9113

Homepage URL


Email

koshikakyotarou@tdc.ac.jp


Sponsor or person

Institute

Tokyo dental college

Institute

Department

Personal name



Funding Source

Organization

Tokyo dental college

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo dental college

Address

2-9-18 Kanda Misaki, Chiyoda, Tokyo

Tel

03-6380-9113

Email

koshikakyotarou@tdc.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 08 Month 03 Day

Date of IRB

2021 Year 08 Month 04 Day

Anticipated trial start date

2021 Year 10 Month 22 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 10 Month 21 Day

Last modified on

2024 Year 03 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052311